Alterity Net Income from 2010 to 2024

ATHE Stock  USD 1.91  0.04  2.05%   
Alterity Therapeutics' Net Loss is decreasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -13 M. During the period from 2010 to 2024 Alterity Therapeutics Net Loss annual values regression line had coefficient of variation of (42.64) and r-squared of  0.60. View All Fundamentals
 
Net Loss  
First Reported
2002-09-30
Previous Quarter
-2.6 M
Current Value
-2.7 M
Quarterly Volatility
1.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alterity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alterity Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 2.9 K, Other Operating Expenses of 9.7 M or Total Operating Expenses of 9.7 M, as well as many indicators such as Price To Sales Ratio of 3.7 K, Dividend Yield of 0.0 or PTB Ratio of 424. Alterity financial statements analysis is a perfect complement when working with Alterity Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Alterity Therapeutics Correlation against competitors.
For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.

Latest Alterity Therapeutics' Net Income Growth Pattern

Below is the plot of the Net Income of Alterity Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Alterity Therapeutics financial statement analysis. It represents the amount of money remaining after all of Alterity Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Alterity Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alterity Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (13.81 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Alterity Net Income Regression Statistics

Arithmetic Mean(9,707,502)
Coefficient Of Variation(42.64)
Mean Deviation3,400,358
Median(10,059,684)
Standard Deviation4,139,581
Sample Variance17.1T
Range15.3M
R-Value(0.77)
Mean Square Error7.4T
R-Squared0.60
Significance0.0007
Slope(715,501)
Total Sum of Squares239.9T

Alterity Net Income History

2024-13 M
2023-12.4 M
2022-13.8 M
2021-12.8 M
2020-15.3 M
2019-10.1 M
2018-12.3 M

Other Fundumenentals of Alterity Therapeutics

Alterity Therapeutics Net Income component correlations

About Alterity Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Alterity Therapeutics income statement, its balance sheet, and the statement of cash flows. Alterity Therapeutics investors use historical funamental indicators, such as Alterity Therapeutics's Net Income, to determine how well the company is positioned to perform in the future. Although Alterity Therapeutics investors may use each financial statement separately, they are all related. The changes in Alterity Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alterity Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alterity Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alterity Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-12.4 M-13 M
Net Loss-12.4 M-13 M
Net Loss-12.4 M-13 M
Net Loss(0.01)(0.01)
Net Income Per E B T 0.91  0.80 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Alterity Stock

When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:
Check out the analysis of Alterity Therapeutics Correlation against competitors.
For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alterity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.74)
Revenue Per Share
0.6
Quarterly Revenue Growth
(0.20)
Return On Assets
(0.29)
Return On Equity
(0.54)
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.